Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

697 ARTÍCULOS , VIENDO DEL 391 AL 405

Neuroanatomical correlates and predictors of psychotic symptoms in Alzheimer's disease: A systematic review and meta-analysis

Scarfo S, Marsella AMA, Grigoriadou L, Moshfeghi Y, McGeown WJ.

Neuropsychologia. 2024 Nov 5;204:109006. doi: 10.1016/j.neuropsychologia.2024.109006. Epub 2024 Sep 24.

The mechanisms, hallmarks, and therapies for brain aging and age-related dementia

Jin S, Lu W, Zhang J, Zhang L, Tao F, Zhang Y, Hu X, Liu Q.

Sci Bull (Beijing). 2024 Dec 15;69(23):3756-3776. doi: 10.1016/j.scib.2024.09.005. Epub 2024 Sep 12.

Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementia

Juul Rasmussen I, Luo J, Frikke-Schmidt R.

Atherosclerosis. 2024 Nov;398:118614. doi: 10.1016/j.atherosclerosis.2024.118614. Epub 2024 Sep 21.

Dementia: Common Syndromes and Modifiable Risk and Protective Factors

Jean KR, Dotson VM.

Neurol Clin. 2024 Nov;42(4):793-807. doi: 10.1016/j.ncl.2024.05.005. Epub 2024 Jun 15.

Neuropsychology and Vascular Cognitive Impairment and Dementia

Cavanagh L, Paulsen JS.

Neurol Clin. 2024 Nov;42(4):809-820. doi: 10.1016/j.ncl.2024.05.006. Epub 2024 Jun 29.

[Construction and validation of a test for verbal auditory screening of cognitive alterations (CAVAC)]

Martino P, Cervigni M, Cores EV, Cossini F, Román K, Cuesta C, Esnaola Y Rojas MM, Graviotto G, Gallegos M, Politis D.

Rev Neurol. 2024 Oct 1;79(7):187-197. doi: 10.33588/rn.7907.2024171.

Sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase IV inhibitors and risk of dementia among patients with type 2 diabetes and comorbid mental disorders: A population-based cohort study

Hong B, Lee H, Choi A, Kim WJ, Cho YM, Yon DK, Shin JY.

Diabetes Metab. 2024 Nov;50(6):101581. doi: 10.1016/j.diabet.2024.101581. Epub 2024 Sep 28.

The Mediterranean Diet: A powerful defense against Alzheimer disease-A comprehensive review

Vaziri Y.

Clin Nutr ESPEN. 2024 Dec;64:160-167. doi: 10.1016/j.clnesp.2024.09.020. Epub 2024 Sep 28.

Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab

Fillit H, Seleri Assunção S, Majda T, Ng CD, To TM, Abbass IM, Raimundo K, Wallick C, Tcheremissine OV.

J Prev Alzheimers Dis. 2024;11(5):1251-1259. doi: 10.14283/jpad.2024.115.

Validation of a Community-Based Approach Toward Personalized Dementia Risk Reduction: The Kimel Family Centre for Brain Health and Wellness

Anderson ND, D'Amico D, Rotenberg S, Addis DR, Gillen J, Moore D, Furlano JA, Tan B, Binns M, Santarossa M, Chertkow H.

J Prev Alzheimers Dis. 2024;11(5):1455-1466. doi: 10.14283/jpad.2024.98.

Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a Multi-Country Comparison

Son S, Speechley M, Zou GY, Kivipelto M, Mangialasche F, Feldman HH, Chertkow H, Belleville S, Nygaard H, Hachinski V, Pieruccini-Faria F, Montero-Odasso M.

J Prev Alzheimers Dis. 2024;11(5):1490-1499. doi: 10.14283/jpad.2024.105.

Systematic review of prognostic factors for poor outcome in people living with dementia that can be determined from primary care medical records

Marshall M, Jordan JL, Bajpai R, Nimmons D, Smith TM, Campbell P, Jordan KP.

BMC Geriatr. 2024 Oct 1;24(1):801. doi: 10.1186/s12877-024-05389-0.

Davunetide sex-dependently boosts memory in prodromal Alzheimer's disease

Gozes I, Blatt J, Lobyntseva A.

Transl Psychiatry. 2024 Oct 2;14(1):412. doi: 10.1038/s41398-024-03118-0.

High blood pressure variability in middle age and cognitive decline in the elderly: the search for better predictors of dementia

Coca A, Sebba-Barroso WK.

J Hypertens. 2024 Nov 1;42(11):1889-1890. doi: 10.1097/HJH.0000000000003826. Epub 2024 Oct 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias